Bristol-Myers posts quarterly profit growth of 3%

Bristol-Myers Squibb reports modestly higher first-quarter earnings, stemming in part from solid sales of its pharmaceutical products and increased gross margins.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.